Jpmorgan Chase & CO Bio Sig Technologies, Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
Shares
3 transactions
Others Institutions Holding BSGM
# of Institutions
7Shares Held
88.5KCall Options Held
0Put Options Held
0-
Zeke Capital Advisors, LLC Berwyn, PA70.9KShares$24,8030.0% of portfolio
-
Kerber Rose Wealth Management, LLC Shawano, WI15.2KShares$5,3280.01% of portfolio
-
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L22KShares$7000.0% of portfolio
-
Colonial Trust Advisors Spartanburg, SC200Shares$700.0% of portfolio
-
Sugarloaf Wealth Management, LLC100Shares$350.0% of portfolio
About BioSig Technologies, Inc.
- Ticker BSGM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,814,400
- Market Cap $15.7M
- Description
- BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...